title: Psychological stress, cocaine and natural reward each induce endoplasmic reticulum stress genes in rat brain.
abstract: Our prior research has shown that the transcription of endoplasmic reticulum (ER) stress transcription factors activating transcription factor 3 (ATF3) and ATF4 are induced by amphetamine and restraint stress in rat striatum. However, presently the full extent of ER stress responses to psychological stress or cocaine, and which of the three ER stress pathways is activated is unknown. The current study examines transcriptional responses of key ER stress target genes subsequent to psychological stress or cocaine. Rats were subjected to acute or repeated restraint stress or cocaine treatment and mRNA was isolated from dorsal striatum, medial prefrontal cortex and nucleus accumbens brain tissue. ER stress gene mRNA expression was measured using quantitative polymerase chain reaction (PCR) and RNA sequencing. Restraint stress and cocaine-induced transcription of the classic ER stress-induced genes (BIP, CHOP, ATF3 and GADD34) and of two other ER stress components x-box binding protein 1 (XBP1) and ATF6. In addition, rats living in an enriched environment (large group cage with novel toys changed daily) exhibited rapid induction of GADD34 and ATF3 after 30 min of exploring novel toys, suggesting these genes are also involved in normal non-pathological signaling. However, environmental enrichment, a paradigm that produces protective addiction and depression phenotypes in rats, attenuated the rapid induction of ATF3 and GADD34 after restraint stress. These experiments provide a sensitive measure of ER stress and, more importantly, these results offer good evidence of the activation of ER stress mechanisms from psychological stress, cocaine and natural reward. Thus, ER stress genes may be targets for novel therapeutic targets for depression and addiction.
authors: Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA.
authors: A A
authors: AA
authors: Pavlovsky
authors: D
authors: D
authors: Boehning
authors: D
authors: D
authors: Li
authors: Y
authors: Y
authors: Zhang
authors: X
authors: X
authors: Fan
authors: T A
authors: TA
authors: Green
mesh_terms: D051700:Activating Transcription Factor 3 / Q000096:biosynthesis; D000818:Animals; D000943:Antigens, Differentiation / Q000096:biosynthesis; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003042:Cocaine / Q000008:administration & dosage*; D059865:Endoplasmic Reticulum Stress / Q000187:drug effects / Q000502:physiology*; D005786:Gene Expression Regulation; D008297:Male; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley; D012201:Reward; D012646:Self Administration; D013315:Stress, Psychological / Q000378:metabolism* / Q000523:psychology
chemical_list: D051700:Activating Transcription Factor 3; D000943:Antigens, Differentiation; C497108:Atf3 protein, rat; C489287:Ppp1r15a protein, rat; D011518:Proto-Oncogene Proteins; D003042:Cocaine
references: PLoS One. 2011;6(12):e28946
references: 22174933
references: Nat Rev Mol Cell Biol. 2012 Jan 18;13(2):89-102
references: 22251901
references: Biol Psychiatry. 2007 Jul 15;62(2):141-7
references: 17217928
references: Biochem Soc Trans. 2006 Feb;34(Pt 1):7-11
references: 16246168
references: Psychopharmacology (Berl). 2002 Aug;162(4):373-8
references: 12172690
references: Int J Neuropsychopharmacol. 2009 Oct;12(9):1151-6
references: 19691875
references: Pharmacol Biochem Behav. 1989 Mar;32(3):683-9
references: 2544904
references: Neurobiol Dis. 2008 Aug;31(2):159-68
references: 18585920
references: J Neurosci. 1996 Aug 1;16(15):4707-15
references: 8764658
references: Psychopharmacology (Berl). 2003 Nov;170(3):235-241
references: 12845407
references: J Neurosci. 2011 Nov 9;31(45):16447-57
references: 22072694
references: Biol Psychiatry. 2008 Aug 15;64(4):336-43
references: 18468583
references: Int J Neuropsychopharmacol. 2009 Mar;12(2):281-3
references: 19154631
references: Behav Brain Res. 1999 Feb 15;99(1):53-60
references: 10512572
references: J Neurosci. 2006 Aug 9;26(32):8235-42
references: 16899718
references: Psychiatry Res. 2009 Aug 15;168(3):209-12
references: 19564049
references: Psychopharmacology (Berl). 2007 Dec;195(3):407-14
references: 17849098
references: Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17145-50
references: 18955698
references: Psychopharmacology (Berl). 2009 Apr;203(3):561-70
references: 19005643
references: Biol Psychiatry. 2010 Jan 1;67(1):28-35
references: 19709647
references: J Neurosci. 2008 Feb 27;28(9):2025-32
references: 18305237
references: Neuroscience. 2007 Mar 16;145(2):621-30
references: 17303341
references: Neuroscience. 2010 Dec 29;171(4):1187-96
references: 20933585
references: Int J Neuropsychopharmacol. 2009 Feb;12(1):33-43
references: 18771604
references: PLoS One. 2009 Jun 30;4(6):e6092
references: 19564919
references: J Neurosci. 2009 Mar 18;29(11):3529-37
references: 19295158
references: Schizophr Bull. 2007 Nov;33(6):1343-53
references: 17329232